0% found this document useful (0 votes)
29 views21 pages

6 Bleeding Disorders

This document discusses bleeding disorders and transfusion medicine. It covers topics such as coagulation pathways, inherited and acquired bleeding disorders, platelet disorders, and approaches to evaluating bleeding disorders. The causes, symptoms, and laboratory tests for conditions like hemophilia, von Willebrand disease, thrombocytopenia, and disseminated intravascular coagulation are summarized. Evaluation of bleeding disorders involves assessing bleeding history, performing platelet counts and coagulation tests, and determining if deficiencies exist in specific coagulation factors.

Uploaded by

rithesh reddy
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
29 views21 pages

6 Bleeding Disorders

This document discusses bleeding disorders and transfusion medicine. It covers topics such as coagulation pathways, inherited and acquired bleeding disorders, platelet disorders, and approaches to evaluating bleeding disorders. The causes, symptoms, and laboratory tests for conditions like hemophilia, von Willebrand disease, thrombocytopenia, and disseminated intravascular coagulation are summarized. Evaluation of bleeding disorders involves assessing bleeding history, performing platelet counts and coagulation tests, and determining if deficiencies exist in specific coagulation factors.

Uploaded by

rithesh reddy
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 21

“6.

Bleeding disorders and


Transfusion Medicine”

by Dr Devesh Mishra
MBBS, MD , AIIMS
Telegram channel Instagram
Rge
< Endothelium
·
D

stabil ↓ G-Anticoagulants ↓


~Heparin"-like mole."N Thrombomodulin(tm)
A I ↓Struct, change
22.
Natural
"h" AT- -
anticoag
-
"Thrombin
I Thrombin
te Canticoagul
inactivate
Synth

[Pro-oag) ⑰
2


protein/s
liver -
2

#, IX to A
inactiv
& ↓ 2
22.

Trans-
mc Hered.
#
tr Leiden
E
thromb mutation

[A U) thmb
+

Young.
Adults.
Alcoholic Liver Disease

22;Gamma ↓

Harboxylation vit. K-
=
depend. ClotFactors

22.
Glutamate
X

2, 7, 9, 10
-
i 20
coagulation path -

22 I
=1165.

i
Intrinsic:aPTT Extrinsic PT
s
=

Har
·

ll I -> tissue-ing

*
-
-

x
·
"vely" charged
H
Glass, si
#
Le tissue
thromboplastin
R

Kaolin
* #a
·

·
PL

Plastic common
sy
-->
-

-vials.= Ea
-

-Cat
Prothrombin
V
7 Thrombina
Y
"Fibre-be
fibrinogenanilisingt
>

401.

FIBRIM
Factor.
Lines
clot-lysis

↓ 22.
~Plasmin
Pla(i)sminogen
Fibrin"->FDP
Itibgra.e -
Bleeding-disorders

Approach
A ↓
Minor Major
↓ -

Petechine/purpura
=

Al
·
Spont. Hematoma
(muscl)
Skin/ Mucosa. ·
Hemarthrosis.
A (Recurr, jointpains
pH-disord -,
Clot-Factor is
2) PH-count (1.5=4.5 lans/mm]

T
*
2] BT [2-gming
-
-

function of pu
Hemophilia
X ↓ ↓
A - B
- &
-
·
AR
XR-Mr
·

· Mc
Hemarthrosis.
·

mptom.
I
I
Lab -

I
-PI-cou=N
-
BT M
=

PT M
-

sated
aPTT4 =
Platelet-disorders
-

↓ -
qualitative BT4
20.
quantitative
22. Fun,
=

defect-=
I
H
Plt-count M N
Plt-count =1,e4
2 =
=

22
PI"functional defect &
BT 4
=

X
Bernard-soulier dis[BSDI
-
1 -

Glanzmann'sthrombosthenia
"YUWD
[T]
Thrombocytopenia
VWE,

I still he


Miimpfu.
quantitative pHdis
Coomb'stest& ana:
Thrombocytopenia
=

b
A ↓ ↓
Immunogenic Non-Immunogenic -> CT-ve

· ge A X -
pH-dest TTP HUS
Eg4-
22

⑭ ADAM-TS-13 ↓ ⑭
M-Ts
DIC -> t t

agentinAbam-TSts
a
· Abn-Agg
↓ Typical
-Pedia Atypical
Adult
Prevent 5 Thrombotic
-

theI
Thromboppenin E.coli [0157:H7]
Noalwing-
=>

·PItcount &
-

Abn-pit-Agy. I
·

completo
shigative
-

clot to
·

cr
=> PI 1; BT4 Flow-t
-
↓ factor Ad
t Pit dest
-

, 4: Srfibrinogent, /
ADAMTS 13

-

·
FDP4 ⑪ ⑭
TTP HUS.
AR >ST AR
-BSD ·

dis.
defect
M P
--
Gpzblsa
Y P2bapIt
⑪11
s
Aggreg
fibrinogene
·enPltesi (are
a

2
② -
WW

-
- -

Weibel -
Palade
Bodies.
ABO inaut
=> MAG- M-Acetyl--Galactosamine
X 9 > Galactose

H-gene
I9
↓ 11

④2 H-substance
it 2 Y⑰ - ↳
2. I

MAG 4 MAG +9 H

X
A 99
If ↑S

RBC =
A
E
AAg
B
*
Bag. AB
e
---
Bag Hag
k

surface

Y
- X Y
anti-A
Serum - anti B anti-A No-ab
- anti-B.
"A, B,
Secretors.-
Al
H-y.
⑬ RBC-sur

Body fuid -> except->Se


·
Serum
·
# Secretors. -> A, B, H-ag>
present, an

Blende 2
1955
A Virate

Blood p
Bombay
22 22.
#
AR = Ih
11
-gene absent
-


-

Blood 9p

Absent
RBC
-> A, B,
H-ag- requiring transf
22
Non-Secretors a X
from
same old Ip
Serum o anti-A, B, H present.
=

ONLY"
A

-Bombay. blood

&
Storage temp Shelf-life
whole Blood Als
↓ 2

⑧ -
components

I 256° ·

I 42
days
2] PRBC ↑

Room-tea. & &

2] telets. · [20 252) >


5-days
-


I
- contagitation
3] FFP
> 12c or ---
1
yr.
-

y Cryoprecipitate lower
-
Blood
Bag Anz
-

A
Additives 21) Glucose/ Dextrose
Nutrition
to RBC
2.

2) A DI 21d. Buffer.
2) Phosphate->
-

pit
-

2] CPD I
XXXX
maintain
Rec
22.
- chelation
3) Citrate= I of cate
o 3] <PD-A -5days.
=>

> ↓
- clot
batt No
42
tetany -

4 SAGM >
days -

ex4) Adenine - ATPsyn -


Stabili
RBCMemb
A
-

life span.
5) Saline
Maintain
=>

RBL
isotonicity
67 Mannitol
I

prevent hemolysis.
Indications BT
of
1) Whole Blood -> Hypovol. Shock Ium,
Anemia.
2) Packed RBC ->

seeafor factor,
trauma
3] FEP ->
e

a
cryoprecipitate # - Hempt.A

&
VNF >VWD

EIll-.d,
- A fibrinogenia

fibrinogen

protocol
Transfusion
↓ 222.

Whole,Blood/PRBC
**
*

· Start transfusion (in> einmin


· Complete transfusion (in s
e
FyrP] mm.Forin
-

the
--
Transfusion Reactions
X I
f

Infections
22.
· MC MCCOD in BT.

extemol y ti c * Al

For
[
2
HIV-1in
-
TRALI * TACO
HCV
Au Transfu Related TransAssoc
=>

HBV
Acute lung in. Overload
->

Cardiac
Malaria
-
Ein "6"
Syphilis, his
·
=>
· cin 12 hrs.
fever -

Tc4
=BN, diuretic
best
BMP
N
q4
BT => > 1 Blood ein 24 his
Massive
-
volume

Al
5L= 10 Blood bags. MBT not alw-

A
complications Art
1

~
KT
Hypothermia, cat
-

feta
are E
↑ catt
=

Metab. Alkalosi's

linersalesas the
A MBT - notalw

AGI bigt
--
4
2+ -

] X
v
- xkt
2

↳Mg2t
ris
DilutionalCoagulopathy
asin the
- Hypothermia
v Metab. Alkalosis.
# Mc-LOD.> in Massive BT
N

Dil.CD

#Fixed component-ratio

PRBC: "Platelets: Ftp
I :1 e I
v Subscribe “DPMA-e-learning Pathology lecture app” by Dr
Devesh Mishra @ website: https://dpma.co.in/

v Pathology Books and Notes by Dr Devesh Mishra@


website: https://devaanshpublications.com/
v Instagram Link:
https://www.instagram.com/devesh.mishra.9/channel/?hl=en
v You tube link:
https://www.youtube.com/c/DrDeveshMishra

v Telegram channel: Dr Devesh Mishra (Pathology):


https://t.me/DrDeveshMishra555

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy